Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer.
Dev H, Linch M, Narahari K, Milne-Clark T, Cheung M, Warren A, Malaviya A, Gnanapragasam V, Hernandez T, Bullock N, Machin A, Dayimu A, Robb T, Cromwell E, Freeman A, Harrington EA, Camacho N, Glont S, Squatrito M, Rotem A, Moore L, Hanson R, Dodd M, Anand S, Kynaston H, Shaw G, Shah N, Pacey S.
Dev H, et al. Among authors: machin a.
Clin Cancer Res. 2025 Jun 13;31(12):2347-2357. doi: 10.1158/1078-0432.CCR-24-1304.
Clin Cancer Res. 2025.
PMID: 40358364
Free PMC article.
Clinical Trial.